- Profile
- Personal Information
- Publications
Experts in Toxicology
Dr. Rama Kant Singh KREMZER Oleksandr Andreevich Vladimir Katanaev Marie-Christine Broillet Karen L. Martin Rhonda Rosengren Lauren Aleksunes Kenneth Bart Kousik Pramanick Shankar Munusamy Dr. Sharad Sharma Dr. Srikanta Kumar Rath DR. Raj Kamal Tripathi Dr. Aamir Nazir Dr. Sarika Singh Kenneth S. Korach Danielle Carlin Freya Kamel Abhayachandran.K Dr. Pradeep Bhatnagar View MoreHAN-FEI LIN
INDEPENDENT DIRECTOR
pharmaceutical
Lotus Pharmaceuticals
Taiwan
Mr. Lin joined Lotus’s Board of Directors on June 27th, 2016. He is currently a Partner with the CID Group, one of the fastest growing venture capital and private equity firms in Asia. Previously, Han-Fei was the Chief Finance Officer of MStar Semiconductor, Inc., a leading IC design firm with a broad range of technologies serving the world’s top consumer electronics and communications companies. During his tenure, he successfully brought the company public with introducing Temasek and GIC as anchor investors, and the deal is still one of the largest IPO in Taiwan’s history. He also played a critical role in negotiating and executing MStar’s merger with Mediatek, which created one of the largest fabless IC design houses in the world. Prior to CID and MStar, Han-Fei served as Director of Investments at Foxconn, and founded and served as CEO of Asia Bioinnovations, a biotech firm located in the Bay Area of California.
Finance and Toxicology